SAGE

Sage Therapeutics
SAGE

Overview Fund Activity
Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

92 hedge funds and large institutions have $1.08B invested in Sage Therapeutics in 2015 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 35 increasing their positions, 15 reducing their positions, and 12 closing their positions.

Holders
92
Holders Change
+19
Holders Change %
+26.03%
% of All Funds
2.45%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
31
Increased
35
Reduced
15
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$39.9M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$31.3M
3
Franklin Resources
3
Franklin Resources
California
$29.5M
4
ORI
4
Oak Ridge Investments
Illinois
$19.4M
5
DM
5
Deerfield Management
New York
$29.9M

Top Sellers

1
TRV
1
Third Rock Ventures
Massachusetts
$491M
2
EC
2
EcoR1 Capital
California
$5.65M
3
FCMI
3
Foresite Capital Management II
California
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$656K
5
NI
5
Numeric Investors
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BPBT
101
Boston Private Bank & Trust
Massachusetts
– – -1,000 Closed
SFU
102
Stonehage Fleming (UK)
United Kingdom
– – -435 Closed
KTC
103
Kistler-Tiffany Companies
Pennsylvania
– – -4 Closed
HNB
104
Huntington National Bank
Ohio
$0 13 +13 New
1 2 3 4
5